Guangzhou (1)

NK/T Cell Lymphoma (1)

Non-Hodgkin Lymphoma (1)

Vascular Immunomother T Cell Lymphoma (1)

Not yet recruiting (1)

phase 1/phase 2 (1)

Sichuan Baili Pharmaceutical Co., Ltd. (1)

SystImmune Inc. (1)

gnc-038 (1)

drug (1)

Industry (1)

Interventional (1)

vascular immunomother t cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Jan 12, 2023